Previous 10 | Next 10 |
home / stock / nriff / nriff news
MISSISSAUGA, ON , July 27, 2020 /PRNewswire/ - Nuvo Pharmaceuticals Inc. (Nuvo or the Company) (TSX: NRI) (OTCQX: NRIFF), a Canadian-focused healthcare company with global reach and a diversified portfolio of commercial products, today announced it expects to release its second quart...
Nuvo Pharmaceuticals Inc (NRIFF) Q1 2020 Earnings Conference Call May 11, 2020 09:00 AM ET Company Participants Rob Harris - Executive Chairman Tina Loucaides - Vice President, Secretary & General Counsel Mary Aprile - Executive Assistant Kelly Demerino - Interim Chief Fina...
Nuvo Pharmaceuticals® Announces Director Election Results of its Annual & Special Meeting of Shareholders Nuvo Pharmaceuticals® Announces Director Election Results of its Annual & Special Meeting of Shareholders Canada NewsWire MISSISSAUGA, ON, May 12, 2020 ...
Nuvo Pharmaceuticals ( OTCQX:NRIFF ): Q1 Adjusted EBITDA of C$8M More news on: Nuvo Pharmaceuticals Inc, Earnings news and commentary, Healthcare stocks news, , Read more ...
Nuvo Pharmaceuticals® Announces First Quarter 2020 Results Canada NewsWire MISSISSAUGA, ON, May 11, 2020 ٠ Q1 2020 Adjusted Total Revenue - $18.9 million ٠ ٠ Q1 2020 Adjusted EBITDA - $8.0 million ٠ ٠ ...
MISSISSAUGA, ON , April 27, 2020 /PRNewswire/ - Nuvo Pharmaceuticals Inc. (Nuvo or the Company) (TSX:NRI; OTCQX:NRIFF), a Canadian focused, healthcare company with global reach and a diversified portfolio of commercial products, today announced it expects to release its first quarter...
- Takeda holds a non-exclusive license to Nuvo's Yosprala ™ patent permitting it to market Capbirin in Japan - MISSISSAUGA, ON , March 31, 2020 /PRNewswire/ - Nuvo Pharmaceuticals Inc. (Nuvo or the Company) (TSX:NRI; OTCQX:NRIFF), a Canadian focused healthcare co...
NEW YORK, March 30, 2020 (GLOBE NEWSWIRE) -- Life Sciences Investor Forum today announced that the presentations from its inaugural conference are now available for on-demand viewing at LifeSciencesInvestorForum.com. This virtual event showcased live company presentations and interactive...
NEW YORK, March 24, 2020 (GLOBE NEWSWIRE) -- Life Sciences Investor Forum today announced the agenda for its inaugural event for public and private companies, investors and industry professionals from around the world. This day-long virtual event will showcase live company presentations and...
MISSISSAUGA, Ontario, March 23, 2020 (GLOBE NEWSWIRE) -- Nuvo Pharmaceuticals Inc. (Nuvo or the Company) (TSX:NRI; OTCQX:NRIFF), a Canadian focused healthcare company with global reach and a diversified portfolio of commercial products, today announced Jesse Ledger, Nuvo’s President ...
News, Short Squeeze, Breakout and More Instantly...
Nuvo Research Inc Company Name:
NRIFF Stock Symbol:
OTCMKTS Market:
Miravo HealthcareTM Ireland Enters into Suvexx® License and Supply Agreement with SK Chemicals Co., Ltd. for South Korea Canada NewsWire - First Asian Partnering Deal for Suvexx - - Up to EUR 1.1 million in upfront and milestone payments - ...
Miravo Healthcare™ Ireland Enters into Suvexx® License and Supply Agreement with Orion Corporation for Select EU Markets PR Newswire - First European Partnering Deal for Suvexx - - Up to EUR 1.7 million in upfront and milestone payments -...
Nuvo Pharmaceuticals® Announces Corporate Rebranding as Miravo Healthcare™ - Consolidates to One Single Corporate Brand Identity - MISSISSAUGA, ON , Dec. 18, 2020 /CNW/ - Nuvo Pharmaceuticals Inc. (TSX:NRI) (OTCQX:NRIFF) d/b/...